1. Home
  2. MRAM vs ANVS Comparison

MRAM vs ANVS Comparison

Compare MRAM & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$9.20

Market Cap

214.4M

Sector

Technology

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$3.55

Market Cap

111.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
ANVS
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
214.4M
111.3M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
MRAM
ANVS
Price
$9.20
$3.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$10.50
$13.50
AVG Volume (30 Days)
153.0K
847.8K
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,642,000.00
N/A
Revenue This Year
$11.00
N/A
Revenue Next Year
$9.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$1.11
52 Week High
$12.27
$5.60

Technical Indicators

Market Signals
Indicator
MRAM
ANVS
Relative Strength Index (RSI) 52.77 45.93
Support Level $8.38 $3.49
Resistance Level $9.55 $3.72
Average True Range (ATR) 0.43 0.34
MACD 0.06 -0.13
Stochastic Oscillator 57.58 4.24

Price Performance

Historical Comparison
MRAM
ANVS

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Share on Social Networks: